Fulgent Genetics (FLGT) Non Operating Income (2015 - 2026)

Fulgent Genetics has disclosed Non Operating Income across 9 years of filings, most recently posting $6.4 million for Q2 2026.

• In Q2 2026, Non Operating Income rose 453.43% year-over-year to $6.4 million; the TTM figure through Jun 2026 stood at $29.8 million (up 131.2% YoY), while the FY2025 annual figure was $21.1 million, down 4.06% from the prior year.
• Non Operating Income came in at $6.4 million for Q2 2026 at Fulgent Genetics, down from $8.6 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $8.6 million in Q1 2026 to a low of -$1.8 million in Q2 2025.
• Average Non Operating Income over 4 years is $5.9 million, with a median of $7.3 million recorded in 2024.
• The largest YoY upside for Non Operating Income was 639.64% in 2025 against a maximum downside of 123.48% in 2025.
• Over 4 years, Non Operating Income stood at $5.9 million in 2023, then soared by 36.54% to $8.1 million in 2024, then retreated by 13.92% to $7.0 million in 2025, then declined by 8.34% to $6.4 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $6.4 million in Q2 2026, $8.6 million in Q1 2026, and $7.0 million in Q4 2025.